The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A prospective, single-arm, open-label, phase 2 study.
 
Lin Gui
No Relationships to Disclose
 
Xinrui Chen
No Relationships to Disclose
 
Zucheng Xie
No Relationships to Disclose
 
Xiaohui He
No Relationships to Disclose
 
Jianliang Yang
No Relationships to Disclose
 
Peng Liu
No Relationships to Disclose
 
Yan Qin
No Relationships to Disclose
 
Yuankai Shi
No Relationships to Disclose